Primecap Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Hold
957,420
﹤0.01% 299
2025
Q4
$1.29M Sell
957,420
-5,200
-0.5% -$7.57K ﹤0.01% 309
2025
Q3
$1.45M Sell
962,620
-65,000
-6% -$97.4K ﹤0.01% 310
2025
Q2
$1.19M Sell
1,027,620
-237,000
-19% -$313K ﹤0.01% 315
2025
Q1
$2.01M Sell
1,264,620
-256,010
-17% -$552K ﹤0.01% 303
2024
Q4
$4.61M Buy
1,520,630
+22,600
+2% +$74.1K ﹤0.01% 278
2024
Q3
$5.51M Buy
1,498,030
+265,690
+22% +$966K ﹤0.01% 282
2024
Q2
$5.04M Buy
1,232,340
+67,730
+6% +$756K ﹤0.01% 279
2024
Q1
$18.4M Buy
1,164,610
+141,260
+14% +$1.94M 0.01% 231
2023
Q4
$15.5M Sell
1,023,350
-10,400
-1% -$152K 0.01% 241
2023
Q3
$20.7M Sell
1,033,750
-77,400
-7% -$1.96M 0.02% 229
2023
Q2
$31.3M Sell
1,111,150
-17,770
-2% -$426K 0.03% 207
2023
Q1
$19.4M Sell
1,128,920
-1,250
-0.1% -$25.3K 0.02% 228
2022
Q4
$22.8M Sell
1,130,170
-49,530
-4% -$1.07M 0.02% 212
2022
Q3
$25.6M Sell
1,179,700
-12,300
-1% -$336K 0.02% 202
2022
Q2
$33.5M Sell
1,192,000
-16,590
-1% -$439K 0.03% 192
2022
Q1
$55.8M Sell
1,208,590
-45,050
-4% -$2.43M 0.04% 179
2021
Q4
$105M Sell
1,253,640
-81,980
-6% -$6.34M 0.07% 157
2021
Q3
$89M Sell
1,335,620
-12,990
-1% -$749K 0.06% 160
2021
Q2
$71.7M Buy
1,348,610
+13,180
+1% +$706K 0.05% 176
2021
Q1
$57.9M Sell
1,335,430
-36,260
-3% -$1.56M 0.04% 185
2020
Q4
$71.2M Sell
1,371,690
-11,060
-0.8% -$499K 0.05% 169
2020
Q3
$45.2M Buy
1,382,750
+722,800
+110% +$25.3M 0.04% 171
2020
Q2
$31.7M Buy
+659,950
New +$25.3M 0.03% 184

Other funds holding ZNTL